A Pilot Study of IRE for Resectable Pancreatic Cancer
A legfontosabb adatok
- Ki végzi
- University of Saskatchewan
- Hol
- Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Visszavonva
- Kezdés
- 2021. okt. 1.
- Befejezés
- 2025. jan.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Irreversible Electroporation
- A regiszteradat frissítve
- 2021. május 6.
- Miért állt le
- We have been unable to secure funding. Now we are in the middle of a pandemic.
Ki vehet részt
- Életkor
- 18 év – 75 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Biopsy-proven pancreatic adenocarcinoma of the head of the pancreas
- Age 18 to 75
- Ability to understand and the willingness to sign a written informed consent document
Ki nem vehet részt
- Patients with cardiac arrhythmia other than rate controlled atrial fibrillation
- Unresectable or locally advanced pancreatic cancer
- Pregnancy
- Subjects who are medically unfit to receive a general anesthetic
- Tumors greater than 3 cm
- Patients with a high suspicion for lymph node metastasis or peripancreatic pathologic (> 1 cm) lymph nodes on imaging
- Metastatic pancreatic carcinoma, including unexpected peritoneal or liver metastases discovered at the time of laparotomy for planned IRE
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The operation to remove certain pancreatic cancers (Whipple procedure), even in 2017, remains one of the most complicated surgeries done in the abdomen. It carries a 50% chance of a complication, even in the world's largest pancreatic surgery centres.
A teljes eredeti leírásKevesebb
Saskatchewan is one of only two centres in Canada to have a promising new technology called Irreversible Electroporation (IRE) (NanoKnife®) available to our patients for the ablation (destruction) of cancers. IRE is different from other ablation treatments, including heat and even radiation, in that with IRE no heat is generated and there is minimal, if any, damage to nearby blood vessels, bowel, and ducts. Thus far, IRE has only been used as a "last resort" in cases where the pancreatic cancer cannot be removed with surgery, yet many patients whose tumor could likely be removed with a 'Whipple' have expressed a preference to undergo IRE instead of the Whipple procedure.
Our main research questions are: In comparison to Whipple procedure, is IRE an effective treatment of pancreatic cancer, and are complications reduced? Is IRE cost-effective? Based on the cases we have done and published series of IRE for stage III pancreatic cancer, we believe that IRE will be effective and safe in treating lesser stage (I and II) tumors in our proposed study.
This will be a pilot study of 12-15 patients, and all recruited patients will receive the IRE treatment and then be followed for up to 5 years for quality of life, recurrence, survival, and cost.
A vizsgálat csoportja
- Study groupA vizsgált kezelés
All patients in this pilot study are in the same group. All receive Irreversible Electroporation.
Kezelés: Irreversible Electroporation
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas
- A regiszteradat frissítve
- 2021. május 6.